Impact of intraoperative radiotherapy vs. whole-breast external beam radiotherapy for early breast cancer: a propensity score matching study based on SEER database.

IF 1.6 3区 医学 Q3 SURGERY
Gland surgery Pub Date : 2025-06-30 Epub Date: 2025-06-26 DOI:10.21037/gs-2025-52
Lin Ding, Huaqian Mo, Yaping Yang, Qingjian Li, Zhuofei Bi
{"title":"Impact of intraoperative radiotherapy <i>vs.</i> whole-breast external beam radiotherapy for early breast cancer: a propensity score matching study based on SEER database.","authors":"Lin Ding, Huaqian Mo, Yaping Yang, Qingjian Li, Zhuofei Bi","doi":"10.21037/gs-2025-52","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Breast-conserving surgery (BCS) followed by adjuvant whole-breast external beam radiotherapy (WBRT) is a standard treatment for early-stage breast cancer, effectively reducing local recurrence and improving survival. However, WBRT involves a prolonged treatment schedule and may lead to adverse effects and reduced patient compliance. Intraoperative radiotherapy (IORT), as a form of accelerated partial breast irradiation (APBI), offers a shorter treatment course by delivering a single dose of radiation during surgery. Although randomized controlled trials suggest comparable survival outcomes between IORT and WBRT in selected patients, real-world evidence is limited. This study aimed to compare the effects of IORT and WBRT on survival outcomes in early-stage breast cancer patients who underwent BCS, using a population-based dataset.</p><p><strong>Methods: </strong>Data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2019. Patients who received either IORT or WBRT after BCS were included. Overall survival (OS) and cancer-specific survival (CSS) were assessed using Kaplan-Meier methods. Cox proportional hazards regression was performed to identify independent prognostic factors.</p><p><strong>Results: </strong>There was no statistically significant difference in OS and CSS between the IORT and WBRT groups. Factors associated with worse survival included older age, T2 stage, and higher tumor grade (all P<0.01). Positive estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status were significantly associated with improved survival (all P<0.01).</p><p><strong>Conclusions: </strong>IORT is an effective alternative to WBRT with equivalent long-term survival. IORT may be considered for eligible patients based on age, tumor size, receptor status, and grade. Prospective studies are warranted to optimize the selection criteria.</p>","PeriodicalId":12760,"journal":{"name":"Gland surgery","volume":"14 6","pages":"1012-1023"},"PeriodicalIF":1.6000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12261243/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gland surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/gs-2025-52","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Breast-conserving surgery (BCS) followed by adjuvant whole-breast external beam radiotherapy (WBRT) is a standard treatment for early-stage breast cancer, effectively reducing local recurrence and improving survival. However, WBRT involves a prolonged treatment schedule and may lead to adverse effects and reduced patient compliance. Intraoperative radiotherapy (IORT), as a form of accelerated partial breast irradiation (APBI), offers a shorter treatment course by delivering a single dose of radiation during surgery. Although randomized controlled trials suggest comparable survival outcomes between IORT and WBRT in selected patients, real-world evidence is limited. This study aimed to compare the effects of IORT and WBRT on survival outcomes in early-stage breast cancer patients who underwent BCS, using a population-based dataset.

Methods: Data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database from 2010 to 2019. Patients who received either IORT or WBRT after BCS were included. Overall survival (OS) and cancer-specific survival (CSS) were assessed using Kaplan-Meier methods. Cox proportional hazards regression was performed to identify independent prognostic factors.

Results: There was no statistically significant difference in OS and CSS between the IORT and WBRT groups. Factors associated with worse survival included older age, T2 stage, and higher tumor grade (all P<0.01). Positive estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status were significantly associated with improved survival (all P<0.01).

Conclusions: IORT is an effective alternative to WBRT with equivalent long-term survival. IORT may be considered for eligible patients based on age, tumor size, receptor status, and grade. Prospective studies are warranted to optimize the selection criteria.

Abstract Image

Abstract Image

Abstract Image

术中放疗与全乳外束放疗对早期乳腺癌的影响:基于SEER数据库的倾向评分匹配研究
背景:保乳手术(BCS)加辅助全乳外束放疗(WBRT)是早期乳腺癌的标准治疗方法,可有效减少局部复发,提高生存率。然而,WBRT涉及延长治疗计划,并可能导致不良反应和降低患者依从性。术中放疗(IORT)作为加速部分乳房放疗(APBI)的一种形式,通过在手术期间提供单剂量放疗,缩短了治疗过程。尽管随机对照试验表明,在选定的患者中,IORT和WBRT的生存结果相当,但实际证据有限。本研究旨在比较IORT和WBRT对接受BCS的早期乳腺癌患者生存结果的影响,使用基于人群的数据集。方法:数据取自2010年至2019年的监测、流行病学和最终结果(SEER)数据库。纳入BCS后接受IORT或WBRT的患者。采用Kaplan-Meier法评估总生存期(OS)和癌症特异性生存期(CSS)。采用Cox比例风险回归来确定独立的预后因素。结果:IORT组与WBRT组的OS、CSS差异无统计学意义。与较差的生存率相关的因素包括年龄较大、T2分期和较高的肿瘤分级(均为p)。结论:IORT是WBRT的有效替代方案,具有相同的长期生存率。根据年龄、肿瘤大小、受体状态和分级,可以考虑对符合条件的患者进行IORT。有必要进行前瞻性研究以优化选择标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Gland surgery
Gland surgery Medicine-Surgery
CiteScore
3.60
自引率
0.00%
发文量
113
期刊介绍: Gland Surgery (Gland Surg; GS, Print ISSN 2227-684X; Online ISSN 2227-8575) being indexed by PubMed/PubMed Central, is an open access, peer-review journal launched at May of 2012, published bio-monthly since February 2015.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信